Shield Therapeutics PLC is a commercial stage specialty pharmaceutical company focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals that address areas of high unmet medical need... Show more
Industry PharmaceuticalsOther
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XYLG | 27.55 | 0.17 | +0.62% |
| Global X S&P 500® Covered Call & Gr ETF | |||
| FTHI | 22.78 | 0.07 | +0.31% |
| First Trust BuyWrite Income ETF | |||
| MDY | 566.51 | 1.27 | +0.22% |
| SPDR® S&P MIDCAP 400 ETF Trust | |||
| RSPU | 70.73 | 0.11 | +0.16% |
| Invesco S&P 500® Equal Weight Utilts ETF | |||
| CVSB | 50.86 | 0.02 | +0.04% |
| Calvert Ultra-Short Investment Grade ETF | |||
A.I.dvisor tells us that SHIEF and TLRY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHIEF and TLRY's prices will move in lockstep.
| Ticker / NAME | Correlation To SHIEF | 1D Price Change % | ||
|---|---|---|---|---|
| SHIEF | 100% | +11.27% | ||
| TLRY - SHIEF | 28% Poorly correlated | -2.55% | ||
| CGC - SHIEF | 26% Poorly correlated | -1.61% | ||
| ACB - SHIEF | 25% Poorly correlated | -2.58% | ||
| IMCC - SHIEF | 25% Poorly correlated | -4.86% | ||
| CVSI - SHIEF | 20% Poorly correlated | +1.52% | ||
More | ||||